146 participants
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2024-07-31
- Completion:
- 2027-04-30
Conditions
- Generalized Myasthenia Gravis
Interventions
- DRUG
- OTHER
No Results Yet